485 related articles for article (PubMed ID: 36961457)
21. Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.
Holland WC; Li F; Nath B; Jeffery MM; Stevens M; Melnick ER; Dziura JD; Khidir H; Skains RM; D'Onofrio G; Soares WE
Acad Emerg Med; 2023 Jul; 30(7):709-720. PubMed ID: 36660800
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
[TBL] [Abstract][Full Text] [Related]
23. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
[TBL] [Abstract][Full Text] [Related]
24. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
Hadland SE; Bagley SM; Rodean J; Silverstein M; Levy S; Larochelle MR; Samet JH; Zima BT
JAMA Pediatr; 2018 Nov; 172(11):1029-1037. PubMed ID: 30208470
[TBL] [Abstract][Full Text] [Related]
25. A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD).
Khatri UG; Lee K; Lin T; D'Orazio JL; Patel MS; Shofer FS; Perrone J
J Med Toxicol; 2022 Jul; 18(3):205-213. PubMed ID: 35415804
[TBL] [Abstract][Full Text] [Related]
26. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
27. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
Grove LR; Rao N; Domino ME
Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
[TBL] [Abstract][Full Text] [Related]
28. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
[TBL] [Abstract][Full Text] [Related]
29. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
[TBL] [Abstract][Full Text] [Related]
30. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
[TBL] [Abstract][Full Text] [Related]
31. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
[TBL] [Abstract][Full Text] [Related]
32. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.
Tilhou AS; Dague L; Saloner B; Beemon D; Burns M
JAMA Health Forum; 2022 Mar; 3(3):e220093. PubMed ID: 35977284
[TBL] [Abstract][Full Text] [Related]
33. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
[TBL] [Abstract][Full Text] [Related]
34. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
Medicaid Outcomes Distributed Research Network
J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access.
Treitler P; Nowels M; Samples H; Crystal S
JAMA Netw Open; 2023 May; 6(5):e2312030. PubMed ID: 37145594
[TBL] [Abstract][Full Text] [Related]
36. Adoption of Emergency Department-Initiated Buprenorphine for Patients With Opioid Use Disorder: Secondary Analysis of a Cluster Randomized Trial.
Gao E; Melnick ER; Paek H; Nath B; Taylor RA; Loza AJ
JAMA Netw Open; 2023 Nov; 6(11):e2342786. PubMed ID: 37948075
[TBL] [Abstract][Full Text] [Related]
37. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
; Donohue JM; Jarlenski MP; Kim JY; Tang L; Ahrens K; Allen L; Austin A; Barnes AJ; Burns M; Chang CH; Clark S; Cole E; Crane D; Cunningham P; Idala D; Junker S; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Pauly N; Sheets L; Talbert J; Zivin K; Gordon AJ; Kennedy S
JAMA; 2021 Jul; 326(2):154-164. PubMed ID: 34255008
[TBL] [Abstract][Full Text] [Related]
38. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
Samples H; Williams AR; Olfson M; Crystal S
J Subst Abuse Treat; 2018 Dec; 95():9-17. PubMed ID: 30352671
[TBL] [Abstract][Full Text] [Related]
40. OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.
Tassey TE; Ott GE; Alvanzo AAH; Peirce JM; Antoine D; Buresh ME
J Subst Abuse Treat; 2022 Dec; 143():108895. PubMed ID: 36215913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]